Michelson Diagnostics Opens US Offices And Appoints US Business Development Manager

Optical Coherence Tomography News (Jun 23 2009) Other Business News

Categories:
Applications: Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
Business News: Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
Technology: Broadband Sources, Doppler, Probes, Tunable Sources
Miscellaneous: Jobs & Studentships, Student Theses, Textbooks

Quotes

  1. “ We already have US sales and are experiencing rapid growth of US enquiries in multiple market segments. ”
    By Jon Holmes
  2. “ Michelson Diagnostics has applied their outstanding technology to forward thinking products and I am extremely pleased to be representing the company in the US. ”
    By Kevin C. Oakley

Entities Mentioned


  1. Michelson Diagnostics Opens US Offices And Appoints US Business Development Manager

    Orpington, UK, June 23rd, 2009: Michelson Diagnostics Limited (MDL) announced today that it has opened a sales and support office in the USA. The office is located in Fuquay-Varina, (in the Research Triangle vicinity of Raleigh-Durham), North Carolina, and is headed by Kevin C. Oakley, Business Development Manager (US) for Michelson Diagnostics.

    The new office will act as a hub for growth of MDL’s business in the field of Optical Coherence Tomography (OCT) imaging, which has great applications potential in fields such as skin cancer diagnosis, genetics research and tissue engineering development. The company has no FDA-approved clinical products yet, but is selling an OCT microscope for the scientific research market and recently announced the ‘VivoSight’ in-vivo OCT probe, for which it expects clinical approvals to be granted in Europe imminently.

    "We already have US sales and are experiencing rapid growth of US enquiries in multiple market segments," said Jon Holmes, CEO of Michelson Diagnostics Ltd, "so it makes sense for us to establish a US presence to enable us to pursue these opportunities more effectively and to provide US customers with local support and service."

    Michelson’s latest recruit, Kevin C. Oakley, is an experienced medical imaging executive, with a background in expanding markets and growing sales for small companies with highly innovative medical imaging products. His extensive career includes senior executive positions at Richardson Electronics Ltd. (Medical SBU), InfiMed, Inc., Lodox Systems, Ltd., and TeraRecon Inc.

    "Michelson Diagnostics has applied their outstanding technology to forward thinking products and I am extremely pleased to be representing the company in the US," said Mr Oakley. "Michelson’s novel high-resolution imaging technology, called Multi-Beam Optical Coherence Tomography (OCT), provides a second generation breakthrough in imaging performance offering twice the resolution of first generation OCT systems. This differentiating technological edge makes Michelson Diagnostics the clear leader in OCT. I am honoured to help Michelson establish their presence here in the largest medical imaging market in the world." His contact details are Kevin.Oakley@md-ltd.co.uk and +1 (315) 783-3803.

    For further details about OCT and Michelson Diagnostics, please visit the MDL web site, www.michelsondiagnostics.com.

    About Michelson Diagnostics Ltd

    Michelson Diagnostics Ltd is the UK’s leading independent manufacturer and developer of Optical Coherence Tomography medical imaging equipment. Founded in 2006, it is based in SE London, UK.

    For further information, please contact Michelson Diagnostics direct or their marketing agency, NetDyaLog Limited.

    Bookmark or Share this article


    Related Articles

Login to comment.